Treatment of non cardiac chest pain: a role for hypnotherapy?
ISRCTN | ISRCTN54865517 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN54865517 |
Secondary identifying numbers | RDO/22/33 |
- Submission date
- 30/08/2005
- Registration date
- 07/09/2005
- Last edited
- 26/05/2010
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Peter Whorwell
Scientific
Scientific
Wythenshawe Hospital
Manchester
M23 9LT
United Kingdom
Phone | +44 (0)1612915813 |
---|---|
peter.whorwell@smuht.nwest.nhs.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Scientific title | |
Study objectives | To assess whether hypnotherapy has a role in the treatment of non cardiac chest pain |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Non cardiac chest pain |
Intervention | Patients will be randomised to receive either: 1. 12 sessions of Hypnotherapy or: 2. 12 sessions of supportive listening of equal duration to hypnotherapy plus placebo medication |
Intervention type | Other |
Primary outcome measure | Subjective global assessment of relief of symptoms compared with pre-trial status. |
Secondary outcome measures | To determine whether hypnotherapy improves frequency, severity and duration of non cardiac chest pain, as well as quality of life and psychological status (visual analogue scales). |
Overall study start date | 01/01/2002 |
Completion date | 01/09/2005 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 50 patients |
Key inclusion criteria | Patients with angina-like chest pain who have been shown to have normal coronary arteries and have no other co-existent disease. |
Key exclusion criteria | 1.Patients with proven coronary artery disease 2.Patients with oesophageal reflux disease |
Date of first enrolment | 01/01/2002 |
Date of final enrolment | 01/09/2005 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Wythenshawe Hospital
Manchester
M23 9LT
United Kingdom
M23 9LT
United Kingdom
Sponsor information
Department of Health (UK)
Hospital/treatment centre
Hospital/treatment centre
Institute for Public Health Research and Policy
University of Salford
Humphrey Booth House
Hulme Place
The Crescent
Salford
M5 6QA
England
United Kingdom
Phone | +44 (0)1612952802 |
---|---|
s.m.riley@salford.ac.uk | |
https://ror.org/03sbpja79 |
Funders
Funder type
Government
Department of Health (UK) - NHS Exec Biomedical Funding Scheme (ref: RDO/22/33)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/10/2006 | Yes | No | |
Other publications | resullts | 01/11/2007 | Yes | No |